HPRT1 and colorectal carcinoma: In contrast, the increased HPRT mutation rates we report in this current study in the MSS CRC cell lines are approximately 10–100-fold increased relative to control levels in nonmutator MSS CRC cells and accordingly are designated as ‘intermediate’ elevated levels.